372 related articles for article (PubMed ID: 32986965)
1. Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease.
Lewis CV; Taylor WR
Am J Physiol Heart Circ Physiol; 2020 Dec; 319(6):H1227-H1233. PubMed ID: 32986965
[TBL] [Abstract][Full Text] [Related]
2. Sequence meets function-microbiota and cardiovascular disease.
Kim M; Huda MN; Bennett BJ
Cardiovasc Res; 2022 Jan; 118(2):399-412. PubMed ID: 33537709
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiome as a novel cardiovascular therapeutic target.
Singh V; Yeoh BS; Vijay-Kumar M
Curr Opin Pharmacol; 2016 Apr; 27():8-12. PubMed ID: 26828626
[TBL] [Abstract][Full Text] [Related]
4. The human gut microbiome - a new and exciting avenue in cardiovascular drug discovery.
Du Y; Li X; Su C; Wang L; Jiang J; Hong B
Expert Opin Drug Discov; 2019 Oct; 14(10):1037-1052. PubMed ID: 31315489
[No Abstract] [Full Text] [Related]
5. Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction.
Zhou X; Li J; Guo J; Geng B; Ji W; Zhao Q; Li J; Liu X; Liu J; Guo Z; Cai W; Ma Y; Ren D; Miao J; Chen S; Zhang Z; Chen J; Zhong J; Liu W; Zou M; Li Y; Cai J
Microbiome; 2018 Apr; 6(1):66. PubMed ID: 29615110
[TBL] [Abstract][Full Text] [Related]
6. The gut microbiota as a novel regulator of cardiovascular function and disease.
Battson ML; Lee DM; Weir TL; Gentile CL
J Nutr Biochem; 2018 Jun; 56():1-15. PubMed ID: 29427903
[TBL] [Abstract][Full Text] [Related]
7. Microbiota-Host Crosstalk: A Bridge Between Cardiovascular Risk Factors, Diet, and Cardiovascular Disease.
Amar J
Am J Hypertens; 2018 Jul; 31(8):941-944. PubMed ID: 30016413
[TBL] [Abstract][Full Text] [Related]
8. Endocrine organs of cardiovascular diseases: Gut microbiota.
Jia Q; Xie Y; Lu C; Zhang A; Lu Y; Lv S; Zhang J
J Cell Mol Med; 2019 Apr; 23(4):2314-2323. PubMed ID: 30688023
[TBL] [Abstract][Full Text] [Related]
9. Leaky Gut: Effect of Dietary Fiber and Fats on Microbiome and Intestinal Barrier.
Usuda H; Okamoto T; Wada K
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299233
[TBL] [Abstract][Full Text] [Related]
10. The role of intestinal microbiota in cardiovascular disease.
Jin M; Qian Z; Yin J; Xu W; Zhou X
J Cell Mol Med; 2019 Apr; 23(4):2343-2350. PubMed ID: 30712327
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensives and Antibiotics: Impact on Intestinal Dysfunction and Hypertension.
Lucas SE; Walton SL; Mirabito Colafella KM; Mileto SJ; Lyras D; Denton KM
Hypertension; 2023 Jul; 80(7):1393-1402. PubMed ID: 37039016
[TBL] [Abstract][Full Text] [Related]
12. Counter-regulatory renin-angiotensin system in cardiovascular disease.
Paz Ocaranza M; Riquelme JA; García L; Jalil JE; Chiong M; Santos RAS; Lavandero S
Nat Rev Cardiol; 2020 Feb; 17(2):116-129. PubMed ID: 31427727
[TBL] [Abstract][Full Text] [Related]
13. 27-Hydroxycholesterol contributes to cognitive deficits in APP/PS1 transgenic mice through microbiota dysbiosis and intestinal barrier dysfunction.
Wang Y; An Y; Ma W; Yu H; Lu Y; Zhang X; Wang Y; Liu W; Wang T; Xiao R
J Neuroinflammation; 2020 Jun; 17(1):199. PubMed ID: 32593306
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiota and Cardiovascular Disease.
Witkowski M; Weeks TL; Hazen SL
Circ Res; 2020 Jul; 127(4):553-570. PubMed ID: 32762536
[TBL] [Abstract][Full Text] [Related]
15. The Relationship among Physical Activity, Intestinal Flora, and Cardiovascular Disease.
Yan Q; Zhai W; Yang C; Li Z; Mao L; Zhao M; Wu X
Cardiovasc Ther; 2021; 2021():3364418. PubMed ID: 34729078
[TBL] [Abstract][Full Text] [Related]
16. Role of the gut microbiota in type 2 diabetes and related diseases.
Yang G; Wei J; Liu P; Zhang Q; Tian Y; Hou G; Meng L; Xin Y; Jiang X
Metabolism; 2021 Apr; 117():154712. PubMed ID: 33497712
[TBL] [Abstract][Full Text] [Related]
17. The gut-blood barrier permeability - A new marker in cardiovascular and metabolic diseases?
Ufnal M; Pham K
Med Hypotheses; 2017 Jan; 98():35-37. PubMed ID: 28012600
[TBL] [Abstract][Full Text] [Related]
18. Dietary metabolism, the gut microbiome, and heart failure.
Tang WHW; Li DY; Hazen SL
Nat Rev Cardiol; 2019 Mar; 16(3):137-154. PubMed ID: 30410105
[TBL] [Abstract][Full Text] [Related]
19. Retinoic Acid, Leaky Gut, and Autoimmune Diseases.
Abdelhamid L; Luo XM
Nutrients; 2018 Aug; 10(8):. PubMed ID: 30081517
[TBL] [Abstract][Full Text] [Related]
20. Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health.
Chambers ES; Preston T; Frost G; Morrison DJ
Curr Nutr Rep; 2018 Dec; 7(4):198-206. PubMed ID: 30264354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
